Series D funding round for Tarveda Therapeutics raising $30M in February 2017
Series D funding round for Tarveda Therapeutics raising $30M in February 2017
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$92M
Top Valuation
-
Tarveda Therapeutics raised $30M in a Series D round.
The round was announced on 02/01/17.